Salvia BioElectronics develops a bioelectronic therapy for individuals suffering from chronic migraine and cluster headache. Their MySalvia Therapy utilizes an ultra-thin implant activated by a wearable device to provide drug-free neuromodulation relief. This technology aims to allow millions of people to manage their neurological pain without interruption to daily life.
Funding
$34.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Chronic migraines and cluster headaches affect millions worldwide, significantly impairing quality of life and often proving resistant to traditional pharmaceutical interventions. Current treatment options may be ineffective or cause unwanted side effects, leaving many patients seeking alternative solutions for pain management and neurological function restoration.
Solution
Salvia BioElectronics is developing MySalvia Therapy, a bioelectronic solution that utilizes neuromodulation to provide targeted relief for individuals with chronic migraines and cluster headaches. The therapy involves the implantation of an ultra-thin device designed to deliver gentle electrical pulses to key nerves associated with these conditions. Patients can activate the therapy on-demand using an external wearable device, allowing for personalized and timely intervention. By modulating the electrical signals within the nervous system, MySalvia Therapy aims to reduce the frequency and intensity of attacks, offering a new treatment option for those who have not found adequate relief through conventional methods. The company is also developing a companion mobile app to provide additional support in managing their condition.
Target Audience
The primary target audience includes individuals suffering from chronic migraines and cluster headaches who have not responded well to traditional treatments, as well as neurologists and pain specialists seeking innovative therapeutic options for their patients.
Features
- Ultra-thin implant designed for placement just beneath the skin of the forehead and back of the head
- Targeted neuromodulation therapy delivering gentle electrical pulses to specific nerves
- User-activated, on-demand therapy via an external wearable device (MySalvia Device)
- Potential for reduced frequency and intensity of migraine and cluster headache attacks
- Future MySalvia app for additional patient support and condition management
- -正在进行临床试验以评估安全性和有效性